Boston, MA-NH (1888PressRelease)
November 21, 2008 - The goal of the conference is to provide an overview of the state of the art developments in the field, bringing together a mix of academic, industry (Pharma and Biotech) and public sector experts in an intimate setting that favors the showcase of data, the exchange of ideas and networking. With many breakthroughs in basic science and the widespread use of immune-based therapies in all fields of medicine related to Immunology, the conference offers a timely presence where top scientists and industry leaders gather to discuss the latest breakthroughs and collaborate in the effort to discover cures and treatments for life-threatening diseases.
The Keynote presentation will be given by Dr. Michael Karin, Professor of Pharmacology, Tumor Growth Invasion & Metastasis Program at the University of California, San Diego. The conference also includes a featured presentation by Dr. John Sims, Scientific Executive Director of Inflammation Research at Amgen as well as many other leading researchers in immunology.
For more information on attending, presenting a poster, or sponsoring, please visit http://gtcbio.com/conferenceDetails.aspx?id=141.
ABOUT GTCbio
GTCbio organizes scientific conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO 434 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 256-6460 email: infogtcbio ( @ ) gtcbio dot com
###
